The World Health Organization has launched a major clinical trial to test potential treatments for the Ebola outbreak in DR Congo.
The Ebola treatment trial has officially begun, with the first patient enrolled in a study aimed at finding effective therapies for the Bundibugyo strain of the virus. The World Health Organization (WHO) announced the development on Thursday, saying the trial is being conducted in collaboration with researchers from the Democratic Republic of Congo, Belgium and the United Kingdom.
The trial will test two experimental treatments for the Bundibugyo virus species, which currently has no approved vaccines or medicines. WHO Director-General Tedros Adhanom Ghebreyesus said effective treatments could help save many more lives during the ongoing outbreak.
The Ebola treatment trial comes as the country continues to battle a worsening outbreak that began in May. According to the WHO, more than 1,400 confirmed cases and 438 deaths have been recorded, while additional infections have also been reported in Uganda and France.
Health officials hope the trial will accelerate the search for safe and effective Ebola treatments as efforts continue to contain the outbreak.
READ ALSO: https://alo360.net/venezuela-earthquakes-survivor-rescued/
